跳至主要内容
临床试验/NCT01948323
NCT01948323Unknown不适用

Pregnancy-Related Obesity Prevention Through Education & Communication Technology in AFRICA:The PROTECT-AFRICA STUDY

University of Cape Town4 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,200
试验地点
4
主要终点
To determine a clinically significant difference (absolute difference of ≥10%) in the proportion of participants who gain > 12kg throughout study period will be less in the intervention group compared to the the non-intervention group.

研究概览

简要总结

The purpose of this study is to investigate whether overweight but not obese pregnant African women having unlimited access to a health education-information technology (IT) based intervention package gain weight within the acceptable range of 8-12 kg during the pregnancy period.

Therefore, we hypothesize that unlimited access to health education via an IT-based intervention package has the potential to reduce the onset of obesity in African pregnant women.

To date (Aug 2015), 95% of patients have been recruited, 1320 potential subjects have been screened and 150 enrolled into the study

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • body-mass index (BMI) range of 25.1-29.9 kg/m2
  • Weeks of pregnancy: 16-20
  • singleton pregnancy

排除标准

  • Evidence of pre-existing cardiovascular disease or a metabolic disorder (i.e. gestational diabetes)

结局指标

主要结局

To determine a clinically significant difference (absolute difference of ≥10%) in the proportion of participants who gain > 12kg throughout study period will be less in the intervention group compared to the the non-intervention group.

时间窗: Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum

次要结局

  • Change in plasma Vitamin C levels in both the mother and newborn(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum; newborn: day of delivery, 6 weeks old, 12 weeks old)
  • Change in blood pressure profiles(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum; newborn: day of delivery, 6 weeks old, 12 weeks old)
  • Improved resting heart rate(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum; newborn: day of delivery, 6 weeks old, 12 weeks old)
  • Clinically normal C-reactive protein levels (<1 mg/dL)(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum; newborn: day of delivery, 6 weeks old, 12 weeks old)
  • Improved awareness of food choices(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, 6 weeks postpartum)
  • Change in body composition (fat percentage, body water percentage, bone mass, muscle mass, bone density and visceral fat) of mother.(Mother: Baseline (12-16 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum)
  • To determine what women actually know (and how much they understand) about the risk factors during their pregnancy.(Mother: Baseline (16-20 weeks pregnancy), 24 weeks, 32 weeks, day of delivery, 6 weeks & 12 weeks postpartum)
  • Cost saving potential of intervention from a societal perspective.(September 2015)
  • Apgar score >3(Newborn: Day of delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Karen Sliwa

Professor

University of Cape Town

研究点 (4)

Loading locations...

相似试验